http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110478364-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_352b7633ffa584e2eeaaa97f7795757f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
| filingDate | 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685b1ed49c0873e446715d3b9832b8c0 |
| publicationDate | 2019-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110478364-A |
| titleOfInvention | The purposes of marine algae extract with reducing blood lipid effectiveness |
| abstract | The invention discloses the purposes of the marine algae extract with reducing blood lipid effectiveness, the purposes of the marine algae extract is to be used to prepare reducing blood lipid effervescent tablet.The present invention also provides a kind of oral administration liquor for reducing blood fat, it is active constituent that it, which is by a effective amount of algal polysaccharides, acceptable auxiliary material is added or complementary ingredient is prepared, the ingredient and its parts by weight of oral solution are as follows: 12-18 parts of algal polysaccharides, 18-23 parts of xylitol, 0.5-0.8 parts of Sucralose, 8-12 parts of fruit powder, 6-8 parts of PEG6000,40-50 parts of disintegrating agent, 0.02-0.04 parts of povidone, 0.3-0.8 parts of sweetener.Have the beneficial effect that the purposes that seaweed of the present invention is extracted is to be used to prepare reducing blood lipid effervescent tablet, the marine algae extract sulfate content and molecular weight are reasonable, purity is high, so that hypolipidemic activity is stronger, the Effervescent tablet disintegration time obtained is short, hydroscopicity is low. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115505049-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114271423-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114271423-B |
| priorityDate | 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.